A password will be e-mailed to you.

Cannabis applications include transdermal viscous gels, intranasal products and intraoral products

Kkolosov / iStock / Getty Images Plus Delta 9 Cannabis Inc. has announced it has signed a master licence agreement with NanoSphere Health Sciences, LLC and its Canadian subsidiary, NanoSphere Cannabis International Inc. “The agreement provides Delta 9 with an exclusive licence in Canada to manufacture and sell products made with Nanosphere’s patented technology for the delivery of cannabinoids via nanoparticle technology,” notes a statement from Delta 9 Cannabis, a Winnipeg-based producer, distributor and retailer of legal cannabis for the medical and recreational markets. Delta 9 will pay NanoSphere a licensing fee of $500,000; NanoSphere will equip the production lab and train Delta 9 staff in the production of the NanoSphere Delivery System of Cannabis product line, Delta 9 reports. “Delta 9 and NanoSphere will each receive 50 percent of the gross profit from the sale of NanoSphere technology-based products. The initial term of the agreement is 36 months following the date Health Canada approves the licensed products for sale,” the statement adds. Delta 9 signs agreement to use technology for delivery of cannabinoids via nanoparticles

thumbnail courtesy of thegrowthop.com